Add to Favorites Newsroom RSS Share
fb-shareCancer Research Institute
New York, NY USA

Our News on Newswise

New Report Charts Dramatic Growth in the Global Clinical Trial Landscape for PD-1/L1 Immune Checkpoint Inhibitors

Latest Cancer Research Institute update on the landscape of anti-PD1/L1 checkpoint inhibitor clinical trials
28-Nov-2018 9:00 AM EST Add to Favorites

Updated Global Immuno-Oncology Landscape Report Highlights Robust International Pipeline Marked by Rapid Growth

The Cancer Research Institute has updated its analysis of the global immuno-oncology landscape, published today in Nature Reviews Drug Discovery.
19-Oct-2018 10:05 AM EDT Add to Favorites

Three Scientists to Receive Top Honors From the Cancer Research Institute for Outstanding Contributions to Cancer Immunology and Immunotherapy

The Cancer Research Institute will bestow its highest honors on three scientists who have made fundamental contributions to the fields of immunology and cancer immunotherapy at its annual taking place on Thursday, October 25, 2018, at The...
10-Sep-2018 4:00 PM EDT Add to Favorites

Biotechnology Company Regeneron and Journalist and Filmmaker Perri Peltz to Receive the 2018 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research

he Cancer Research Institute will honor biotechnology company Regeneron, and journalist and filmmaker Perri Peltz with the 2018 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research at its annual gala taking place on Thursday,...
10-Sep-2018 4:00 PM EDT Add to Favorites

New Report on the Global Landscape of Cancer Cell Therapy Highlights Robust International Pipeline Marked by Rapid Growth

Newly published report in Nature Reviews Drug Discovery that provides a comprehensive, independent analysis of the global landscape of cancer cell therapies, including all agents from preclinical to post-market stages.
25-May-2018 7:10 AM EDT Add to Favorites


Cancer Research Institute Celebrates Sixth Annual Cancer Immunotherapy Month™ in June

Month-long awareness and education campaign in June highlighting breakthroughs in cancer treatment with immunotherapy and the urgent need for more research funding
16-May-2018 2:00 PM EDT Add to Favorites


Healthcare Experts Tackle Tough Challenges at Fortune Brainstorm HEALTH 2018

On March 19-20 in California, the third Fortune Brainstorm HEALTH conference brought together renowned leaders from healthcare and related industries to provide insight into today’s most pressing challenges as well as how we might solve them.
29-Mar-2018 3:00 PM EDT Add to Favorites


Cancer Research Institute and Canadian Cancer Trials Group Announce Strategic Collaboration

Two leading non-profits combine efforts to accelerate cancer immunotherapy clinical trials for patients globally
8-Jan-2018 8:30 AM EST Add to Favorites

see all news

Our Experts on Newswise

Expert Available for Commentary on Recent FDA Analysis of TNF Blockers

The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a...
7-Aug-2009 9:00 AM EDT

PROVENGE Cancer Vaccine Heralds New Dawn in Cancer Therapy

Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in...
29-Apr-2009 11:20 AM EDT

see all experts

Our YouTube Videos


The mission of the Cancer Research Institute is to extend the lives of cancer patients and reduce cancer-related deaths by fueling the development of a news class of smarter, more effective treatments that mobilize our body's natural natural immune defenses against all types of cancer.


Brian Brewer
Marketing & Communications Director


Elliot Fox

Twitter twitter-icon

Chat now!